Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 1/20 | 0.44 |
| ▸ | SELL | P14151 | 7/20 | 0.40 |
| ▸ | SELP | P16109 | 7/20 | 0.40 |
| ▸ | IGF2R | P11717 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28090570 | 1.00 | GBA1 (0.44) | GBA1SELLSELPIGF2R | |
| SCHEMBL14906611 | 1.00 | GBA1 (0.44) | GBA1SELLSELPIGF2R | |
| SCHEMBL17188540 | 0.95 | GBA1 (0.52) | GBA1SELLSELPIGF2R | |
| SCHEMBL29290243 | 0.95 | GBA1 (0.52) | GBA1SELLSELPIGF2R | |
| SCHEMBL29785161 | 0.95 | GBA1 (0.52) | GBA1SELLSELPIGF2R | |
| SCHEMBL3178110 | 0.95 | GBA1 (0.52) | GBA1SELLSELPIGF2R | |
| SCHEMBL28866661 | 0.95 | GBA1 (0.52) | GBA1SELLSELPIGF2R | |
| SCHEMBL13429016 | 0.95 | GBA1 (0.52) | GBA1SELLSELPIGF2R | |
| SCHEMBL13063883 | 0.95 | GBA1 (0.52) | GBA1SELLSELPIGF2R | |
| SCHEMBL17188539 | 0.93 | GBA1 (0.55) | GBA1SELLSELPIGF2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230181607-A1 | THIOSACCHARIDES FOR USE IN TREATING CORONAVIRUS INFECTION | The University of the Regents of California (US) | 2023-06-15 | — | — | US | disclosed |
| US-20180111955-A1 | THIOSACCHARIDE MUCOLYTIC AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-04-26 | — | — | US | disclosed |
| US-9856283-B2 | Thiosaccharide mucolytic agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-01-02 | — | — | US | disclosed |
| US-20160060284-A1 | THIOSACCHARIDE MUCOLYTIC AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180111955-A1 | THIOSACCHARIDE MUCOLYTIC AGENTS | MUC1, TREH, FUT6 | GBA1 161/4885SELL 892/4885SELP 390/4885 |
| US-20160060284-A1 | THIOSACCHARIDE MUCOLYTIC AGENTS | MUC1, TREH, FUT6 | GBA1 161/4885SELL 892/4885SELP 390/4885 |
| US-20230181607-A1 | THIOSACCHARIDES FOR USE IN TREATING CORONAVIRUS INFECTION | TMPRSS4, ACE, ACE2 | GBA1 361/4885SELL 1303/4885SELP 686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.